Cruse Michael 4
4 · Reneo Pharmaceuticals, Inc. · Filed Dec 13, 2022
Insider Transaction Report
Form 4
Cruse Michael
Senior VP-Corporate Operations
Transactions
- Award
Stock option (right to buy)
2022-12-09+125,000→ 125,000 totalExercise: $1.80Exp: 2032-12-08→ Common Stock (125,000 underlying)
Holdings
- 13,697(indirect: By Trust)
Common Stock
- 35,758
Common Stock
Footnotes (3)
- [F1]Includes 4,000 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on December 8, 2022.
- [F2]By Michael P. Cruse and Thu Anh Thuy Cruse, Trustees of The Cruse Family Revocable Living Trust.
- [F3]The shares vest in a series of 16 successive equal quarterly installments measured from December 9, 2022 subject to Reporting Person's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) as of each such vesting date.